These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 480401)

  • 41. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K; Yoshikawa N; Nakamura H; Itoh H
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro.
    Fishman JA; Karnovsky MJ
    Am J Pathol; 1985 Mar; 118(3):398-407. PubMed ID: 3976843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased apoptosis in acute puromycin aminonucleoside nephrosis.
    Fernandez L; Romero M; Soto H; Mosquera J
    Exp Nephrol; 2001; 9(2):99-108. PubMed ID: 11150858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of celecoxib and nordihydroguaiaretic acid on puromycin aminonucleoside-induced nephrosis in the rat.
    Lee DW; Kwak IS; Lee SB; Song SH; Seong EY; Chung HC; Yang BY; Lee MY; Sol MY
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S183-8. PubMed ID: 19194550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In glomerular cells of puromycin aminonucleoside nephrosis rats both phosphorylated and total STAT3 levels increased during proteinuria.
    Saygı Hİ; Güngör ZB; Kalay F; Seçkin İ
    Acta Histochem; 2018 Aug; 120(6):595-603. PubMed ID: 30054017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
    Shimo T; Adachi Y; Yamanouchi S; Tsuji S; Kimata T; Umezawa K; Okigaki M; Takaya J; Ikehara S; Kaneko K
    Am J Nephrol; 2013; 37(4):302-9. PubMed ID: 23548793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical studies of the isolated rat glomerulus and the effects of puromycin aminonucleoside administration.
    Bhuyan UN; Welbourn CR; Evans DJ; Peters TJ
    Br J Exp Pathol; 1980 Feb; 61(1):69-75. PubMed ID: 6246912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Puromycin aminonucleoside nephrosis results in a marked increase in fractional clearance of albumin.
    Osicka TM; Hankin AR; Comper WD
    Am J Physiol; 1999 Jul; 277(1):F139-45. PubMed ID: 10409307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.
    Fujiwara Y
    Virchows Arch A Pathol Anat Histopathol; 1984; 405(1):11-24. PubMed ID: 6438895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
    Fernandez L; Romero M; Rincón J; Mosquera J
    Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD; Bertram JF; Ryan GB
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of grape seed extract on puromycin-aminonucleoside-induced nephrosis in rats.
    Mattoo TK; Kovacevic L
    Pediatr Nephrol; 2003 Sep; 18(9):872-7. PubMed ID: 12836089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of olfactomedin-1 and myocilin in podocytes during puromycin aminonucleoside nephrosis.
    Bohr DC; Koch M; Kritzenberger M; Fuchshofer R; Tamm ER
    Nephrol Dial Transplant; 2011 Jan; 26(1):83-92. PubMed ID: 20595200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aminonucleoside nephrosis in PRO/Re mice.
    Kanwar YS; Manaligod JR; Krakower CA
    Proc Soc Exp Biol Med; 1977 Jul; 155(3):339-45. PubMed ID: 877132
    [No Abstract]   [Full Text] [Related]  

  • 58. Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
    Sagae Y; Matsumoto Y; Unno K
    J Pharmacobiodyn; 1983 Jul; 6(7):475-80. PubMed ID: 6358456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats.
    Nakamura K; Kojima K; Arai T; Shirai M; Usutani S; Akimoto H; Masaoka H; Nagase M; Yamamoto M
    Eur J Clin Invest; 1998 Nov; 28(11):877-83. PubMed ID: 9824428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis.
    Groggel GC; Hovingh P; Border WA; Linker A
    Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.